Key statistics
As of last trade, Karyopharm Therapeutics Inc (25K:FRA) traded at 0.8196, 36.55% above the 52 week low of 0.6002 set on Sep 24, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.8196 |
---|---|
High | 0.8196 |
Low | 0.8196 |
Bid | 0.7822 |
Offer | 0.8606 |
Previous close | 0.8642 |
Average volume | 1.72k |
---|---|
Shares outstanding | 125.31m |
Free float | 117.75m |
P/E (TTM) | -- |
Market cap | 112.51m USD |
EPS (TTM) | -0.7906 USD |
Data delayed at least 15 minutes, as of Nov 13 2024 07:43 GMT.
More ▼
Press releases
- Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024
- Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis
- Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024
- Karyopharm to Participate at Upcoming Investor Conferences
More ▼